Company intelligence / Profile preview

Kurma Partners

Paris, Île-de-France, Francekurma.ch ↗
Ownership
Private
Development stage
Other
01

Overview

Kurma Partners has established itself as a leading European venture capital group focused on healthcare innovation. It co-founds and invests in biotech and healthtech startups spun out from top academic research institutions across Europe. Its funds have supported successful exits such as Amolyt Pharma (acquired by AstraZeneca), Emergence Therapeutics (acquired by Eli Lilly), and Corlieve Therapeutics (acquired by BioMarin). The current Biofund IV aims to invest in up to 20 new biotech/healthcare companies developing innovative therapeutics addressing high unmet medical needs.

Therapeutic areas
OncologyEndocrinologyImmunologyOtherNeurology
Modalities
Small moleculeMonoclonal antibodyAntibody-drug conjugateGene therapyRNA therapyDiagnostic & Diagnostic Digital solutions
Industry
Investors
02

Partnerships

Pasteur InstituteSATT Paris-SaclayIRB BarcelonaCSL Limited Partner in fundsAstraZenecaEli Lilly

Beyond the preview

Go deeper on Kurma Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kurma Partners.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call